56. Relling M V., Hancock ML, Boyett JM, Pui CH, Evans WE. 13. Prognostic importance of 6-mercapto purine dose intensity in acute lymphoblastic leuke mia. Blood. 1999;93(9):2817–23. 66. Amir Z, Scully J, Borrill C. The professional role of breast cancer nurses in multi-disciplinary breast can cer care teams. Eur J Oncol Nurs. 2004;8(4):306–14. 67. Pavlish C, Ceronsky L. Oncology nurses’ percep tions of nursing roles and professional attributes in palliative care. Clin J Oncol Nurs. 2009;13(4):404–12. 57. Richards S, Gray R, Peto R, Gaynon P, Masera G, Pession A, et al. Duration and intensity of maintenan ce chemotherapy in acute lymphoblastic leukaemia:
Overview of 42 trials involving 12,000 randomised children. Lancet. 1996;347(9018):1783–8. 68. Crane-Okada R. Evaluation and outcome me asures in patient navigation. Semin Oncol Nurs. 2013;29(2):128–40. 58. Pui CH, Cheng C, Leung W, Rai S, Rivera GK, Sand lund JT, et al. 25. Extended Follow-up of Long-Term Survivors of Childhood Acute Lymphoblastic Leuke mia. NEJM. 2003;349:640–9. 69. Moreno-Castro A, Carrillo-Gonzбlez G-M. El enfer mero navegador: un rol innovdor en oncologнa. Revi siyn de alcance. Arch Med. 2021;21(1):en prensa. 59. Conklin HM, Krull KR, Reddick WE, Pei D, Cheng C, Pui CH. 17.
Cognitive outcomes following contem porary treatment without cranial irradiation for child hood acute lymphoblastic leukemia. J Natl Cancer Inst. 2012;104(18):1386–95. 70. Fillion L, Cook S, Veillette AM, Aubin M, De Se rres M, Rainville F, et al. Professional navigation fra mework: Elaboration and validation in a Canadian context. Oncol Nurs Forum. 2012;39(1). 71. Grimshaw J, Russell I. Effect of clinical guidelines on medical practice : review of rigorous evaluations. Lancet. 1993;342:1317–22. 60. Jacola LM, Krull KR, Pui CH, Pei D, Cheng C, Reddick WE, et al. 15.
Longitudinal assessment of neurocognitive outcomes in survivors of childhood acute lymphoblas tic leukemia treated on a contemporary chemotherapy protocol. J Clin Oncol. 2016;34(11):1239–47. 72. Smith TJ, Hillner BE. Ensuring quality cancer care by the use of clinical practice guidelines and critical pathways. J Clin Oncol. 2001;19(11):2886–97. 61. Kaste SC, Pei D, Cheng C, Neel MD, Bowman WP, Ribeiro RC, et al. 9. Utility of early screening magnetic resonance imaging for extensive hip osteonecrosis in pediatric patients treated with glucocorticoids. J Clin Oncol. 2015;33(6):610–5. 73. Pierson DJ. Translating evidence into practice. Respir Care. 2009;54(10):1386–401. 74.
Heins MJ, De Jong JD, Spronk I, Ho VKY, Brink M, Ko revaar JC. Adherence to cancer treatment guidelines: Influence of general and cancer-specific guideline cha racteristics. Eur J Public Health. 2017;27(4):616–20. 62. Inaba H, Cao X, Han AQ, Panetta JC, Ness KK, Metzger ML, et al. 4. Bone mineral density in chil dren with acute lymphoblastic leukemia. Cancer. 2018;124(5):1025–35. 75. Grol R, Grimshaw J. From best evidence to best practice: Effective implementation of change in pa tients’ care. Lancet. 2003;362(9391):1225–30. 63. Ashford J, Schoffstall C, Reddick W, Loene C, La ningham F, Glass J, et al. 5.
Attention and Working Memory Abilities in Children Treated for Acute Lym phoblastic Leukemia. Cancer. 2010;116(19):4638–4645. 76. Congreso de Colombia. LEY 1122 DE 2007. “Por la cual se hacen algunas modificaciones en el Sistema General de Seguridad Social en Salud y se dictan otras disposiciones” [Internet]. Bogotб DC; 2007 [ci ted 2020 Nov 3]. Available from: https://www.minsa lud.gov.co/sites/rid/Lists/BibliotecaDigital/RIDE/DE/ DIJ/ley-1122-de-2007.pdf 64. Krull KR, Cheung YT, Liu W, Fellah S, Reddick WE, Brinkman TM, et al. 6. Chemotherapy pharmacody namics and neuroimaging and neurocognitive out comes in long-term survivors of childhood acute lym phoblastic leukemia.
J Clin Oncol. 2016;34(22):2644–53. 65. Munro A, Brown M, Niblock P, Steele R, Carey F. Do Multidisciplinary Team (MDT) processes influence survival in patients with colorectal cancer? A popula tion-based experience. BMC Cancer. 2015;15(1):1–9. 77. Taylor A. Five-Step Approach to Stakeholder Enga gement. Bus Soc Responsib [Internet]. 2019;41. Available from: https://www.bsr.org/en/our-insights/report-view/ stakeholder-engagement-five-step-approach-toolkit 87 GUHA DE MANEJO PARA EL DIAGNYSTICO, TRATAMIENTO Y SEGUIMIENTO DE LA LEUCEMIA LINFOBLБSTICA AGUDA PEDIБTRICA, ADAPTADA A LA CIUDAD DE SANTIAGO DE CALI – COLOMBIA